In development: Guidance, quality standards and advice

Skip to filters Skip to results

Showing 21 to 30 of 96

Sort by

Keyword or reference number: in`Remove $Keyword or reference number: in filter`

Guidance, NICE advice and quality standards in development
Title	Type	Expected publication date
Dexmedetomidine for treating agitation associated with bipolar disorder in people 18 to 75 years [TSID10725]	Technology appraisal guidance	TBC
Diabetes in pregnancy: management from preconception to the postnatal period - Managing type 1 diabetes (T1D) using hybrid closed loops (update)	NICE guideline	12 August 2026
Digital technologies delivering CBT for insomnia in adults	Health technology evaluation	6 January 2027
Digital technologies to support smoking cessation in secondary care patients: early value assessment	Health technology evaluation	TBC
Donidalorsen for preventing recurrent attacks of hereditary angioedema in people 12 years and over [ID6457]	Technology appraisal guidance	18 June 2026
Doxecitine–doxribtimine for treating thymidine kinase 2 deficiency in people of any age [ID6484]	Highly specialised technology	TBC
Dupilumab for treating chronic spontaneous urticaria in people 12 years and over [ID4055]	Technology appraisal guidance	TBC
Durvalumab in combination for neoadjuvant and adjuvant treatment of resectable gastric and gastro-oesophageal junction cancer [ID6374]	Technology appraisal guidance	TBC
Elamipretide for treating Barth syndrome in people of any age [ID6545]	Technology appraisal guidance	TBC
Elexacaftor–tezacaftor–ivacaftor with ivacaftor for treating cystic fibrosis without an F508del mutation and with a mutation in the CFTR gene that is responsive to elexacaftor–tezacaftor–ivacaftor in people aged 6 and over [TSID11847]	Technology appraisal guidance	TBC

Results per page

10
25
50
All